• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧琥珀酰抑制剂使木瓜蛋白酶失活的机制研究。

Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.

作者信息

Meara J P, Rich D H

机构信息

School of Pharmacy, University of Wisconsin, Madison 53705, USA.

出版信息

J Med Chem. 1996 Aug 16;39(17):3357-66. doi: 10.1021/jm950445b.

DOI:10.1021/jm950445b
PMID:8765519
Abstract

Analogs of the epoxysuccinyl peptide cysteine proteinase inhibitor, EP-475 (2a), in which the free carboxylate has been replaced by hydroxamic acid, amide, methyl ketone, hydroxyl, and ethyl ester functionalities, have been synthesized. Individual rate constants of inhibition of papain were determined for these inhibitors. The results show that a carbonyl-containing functionality is necessary for good activity. The pH dependence of the inhibition of papain was determined for a nonionizable EP-475 (2a) analog; inhibition was found to depend on two acidic ionizations (pKas of 3.93 and 4.09) of papain. Implications for the mechanism of action of epoxysuccinyl peptides with papain are discussed.

摘要

已合成环氧琥珀酰肽半胱氨酸蛋白酶抑制剂EP - 475(2a)的类似物,其中游离羧酸盐已被异羟肟酸、酰胺、甲基酮、羟基和乙酯官能团取代。测定了这些抑制剂对木瓜蛋白酶的个体抑制速率常数。结果表明,含羰基的官能团对于良好的活性是必需的。测定了一种非离子化的EP - 475(2a)类似物对木瓜蛋白酶抑制作用的pH依赖性;发现抑制作用取决于木瓜蛋白酶的两个酸性电离(pKa分别为3.93和4.09)。讨论了环氧琥珀酰肽与木瓜蛋白酶作用机制的相关问题。

相似文献

1
Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.环氧琥珀酰抑制剂使木瓜蛋白酶失活的机制研究。
J Med Chem. 1996 Aug 16;39(17):3357-66. doi: 10.1021/jm950445b.
2
Inactivation of cysteine proteases.半胱氨酸蛋白酶的失活
Arch Biochem Biophys. 1996 Jun 1;330(1):110-4. doi: 10.1006/abbi.1996.0231.
3
New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.源自亲电α-氨基酸氮丙啶-2,3-二羧酸的新型肽类半胱氨酸蛋白酶抑制剂。
J Med Chem. 1999 Feb 25;42(4):560-72. doi: 10.1021/jm981061z.
4
Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.作为半胱氨酸蛋白酶抑制剂在P'方向上延伸的肽基环氧化合物:对亲和力和抑制机制的影响
Bioorg Med Chem. 2008 Oct 1;16(19):9032-9. doi: 10.1016/j.bmc.2008.08.031. Epub 2008 Aug 19.
5
Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.木瓜蛋白酶家族半胱氨酸蛋白酶环氧琥珀酰基抑制剂的体内效力和选择性的设计、合成及评估
Chem Biol. 2007 May;14(5):499-511. doi: 10.1016/j.chembiol.2007.03.010.
6
Inactivation of cysteine proteases by peptidyl epoxides: characterization of the alkylation sites on the enzyme and the inactivator.肽基环氧化物对半胱氨酸蛋白酶的失活作用:酶和失活剂上烷基化位点的表征
Biochem J. 2000 Feb 15;346 Pt 1(Pt 1):71-6.
7
Solid-phase methods for the preparation of epoxysuccinate-based inhibitors of cysteine proteases.
J Comb Chem. 2006 Nov-Dec;8(6):802-4. doi: 10.1021/cc0601027.
8
Further evidence for the importance of free carboxylate in epoxysuccinate inhibitors of thiol proteases.游离羧酸盐在硫醇蛋白酶环氧琥珀酸抑制剂中的重要性的进一步证据。
J Enzyme Inhib. 1993;7(1):15-25. doi: 10.3109/14756369309020184.
9
Azapeptides as inhibitors and active site titrants for cysteine proteinases.氮杂肽作为半胱氨酸蛋白酶的抑制剂和活性位点滴定剂。
J Med Chem. 1998 Apr 9;41(8):1344-51. doi: 10.1021/jm970802d.
10
Potent inhibitors of cysteine proteases from the marine fungus Microascus longirostris.来自海洋真菌长喙小囊菌的半胱氨酸蛋白酶强效抑制剂。
J Antibiot (Tokyo). 1996 Apr;49(4):395-7. doi: 10.7164/antibiotics.49.395.

引用本文的文献

1
Examination of the impact molecular charge has on NTSR1-targeted agents incorporated with cysteine protease inhibitors.研究分子电荷对与半胱氨酸蛋白酶抑制剂结合的NTSR1靶向药物的影响。
Eur J Med Chem. 2022 Apr 15;234:114241. doi: 10.1016/j.ejmech.2022.114241. Epub 2022 Mar 8.
2
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.半胱氨酸蛋白酶作为治疗靶点:选择性重要吗?对钙蛋白酶和组织蛋白酶抑制剂的系统评价。
Acta Pharm Sin B. 2015 Nov;5(6):506-19. doi: 10.1016/j.apsb.2015.08.001. Epub 2015 Sep 26.
3
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
半胱氨酸组织蛋白酶活性抑制乳腺癌中髓源性抑制细胞的破骨细胞生成。
Oncotarget. 2015 Sep 29;6(29):27008-22. doi: 10.18632/oncotarget.4714.
4
Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer.在胰腺神经内分泌癌小鼠模型中,半胱氨酸蛋白酶组织蛋白酶L的缺乏会损害Myc诱导的肿瘤发生。
PLoS One. 2015 Apr 30;10(4):e0120348. doi: 10.1371/journal.pone.0120348. eCollection 2015.
5
A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression.一种新型半胱氨酸组织蛋白酶抑制剂可导致巨噬细胞死亡和乳腺肿瘤消退。
Oncogene. 2015 Dec 10;34(50):6066-78. doi: 10.1038/onc.2015.51. Epub 2015 Mar 23.
6
Cathepsin B inhibition limits bone metastasis in breast cancer.组织蛋白酶 B 抑制可限制乳腺癌骨转移。
Cancer Res. 2012 Mar 1;72(5):1199-209. doi: 10.1158/0008-5472.CAN-11-2759. Epub 2012 Jan 19.
7
Inhibition of the purified 20S proteasome by non-heme iron complexes.非血红素铁配合物对纯化 20S 蛋白酶体的抑制作用。
Metallomics. 2012 Feb;4(2):174-8. doi: 10.1039/c2mt00131d. Epub 2011 Dec 15.
8
Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.鉴定和临床前试验表明,一种可逆的组织蛋白酶蛋白酶抑制剂在胰腺癌模型中具有抗肿瘤疗效。
Biochimie. 2010 Nov;92(11):1618-24. doi: 10.1016/j.biochi.2010.04.023. Epub 2010 May 4.
9
Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.小鼠组织蛋白酶F缺乏会导致神经元脂褐质沉积症和迟发性神经疾病。
Mol Cell Biol. 2006 Mar;26(6):2309-16. doi: 10.1128/MCB.26.6.2309-2316.2006.
10
Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation.对活抗原呈递细胞中蛋白酶活性的分析表明,在树突状细胞激活过程中,吞噬体蛋白水解成分受到调控。
J Exp Med. 2002 Aug 19;196(4):529-40. doi: 10.1084/jem.20020327.